Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.

about

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.

Item

http://www.wikidata.org/entity/Q54940363

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@en

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@nl

type

Item

label

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@en

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@nl

prefLabel

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@en

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@nl

P1476

Intermittent androgen deprivat ...... e cancer: Connecting the dots.

@en

P2093

Per-Anders Abrahamsson

http://www.w3.org/2001/XMLSchema#string

P2860

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.

Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life.

Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials.

An update on androgen deprivation therapy for prostate cancer.

Androgens, cardiovascular disease and osteoporosis.

Intermittent androgen suppression for rising PSA level after radiotherapy.

International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients.

Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer.

Intermittent versus continuous androgen deprivation in prostate cancer

P304

208-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJUR.2017.04.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29387553

http://www.w3.org/2001/XMLSchema#string

P932

5772839

http://www.w3.org/2001/XMLSchema#string